Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-10-30 |
Court | District Court, N.D. West Virginia | Date Terminated | 2020-03-30 |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 8,877,938; 9,388,134 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-03-09 | 114 | Other Document | and March 1, 2023 trial of U.S. Patent Nos. 8,877,938 and 9,388,134 in this matter, the parties…October 2019 30 March 2020 1:19-cv-00201 Patent - Abbreviated New Drug Applications (ANDA) | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |